They prevent strokes, heart attacks, chronic kidney disease, sleep apnea, and Parkinson's disease
Switching Injection Sites to Reduce GLP-1 Nausea Though there is no scientific evidence supporting the idea that changing the injection site reduces nausea, some patients have reported a possible reduction in nausea by rotating their injection sites
What is a Microdose
TRIUMPH-2 is testing retatrutide in adults living with type 2 diabetes, and TRIUMPH-3 is looking at heart disease outcomes
There may be difficulties in having to refrigerate the injectable versions
This renewed focus on non-COVID indications earlier in development may lead to more self-injection options, such as OTS autoinjectors. Over the past year, devices assembled at Catalent for customers have included anti-needlestick devices and autoinjectors for biologics used to treat autoimmune disorders